Instead, mammalian BP use is affected by recurrent cancer mutations in SF3B1 that reduce BP fidelity to the detriment of accurate 3’ splice site selection (Darman et al. 2015; Alsafadi et al. 2016). Here, SF3B1 is linked to cancer.